Nanobiotix S.A. (NASDAQ:NBTX – Get Free Report)’s share price dropped 1.4% during trading on Wednesday . The company traded as low as $4.93 and last traded at $4.93. Approximately 6,684 shares changed hands during mid-day trading, a decline of 65% from the average daily volume of 19,285 shares. The stock had previously closed at $5.00.
Analysts Set New Price Targets
Separately, Guggenheim initiated coverage on shares of Nanobiotix in a research note on Wednesday, August 28th. They issued a “buy” rating and a $12.00 price objective on the stock.
Check Out Our Latest Stock Report on Nanobiotix
Nanobiotix Price Performance
About Nanobiotix
Nanobiotix SA, a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer.
Featured Articles
- Five stocks we like better than Nanobiotix
- Compound Interest and Why It Matters When Investing
- How Much Can You Make in Stocks in One Month?
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- This Is the Top Large-Cap Stock Insiders Are Buying
- Insider Trading – What You Need to Know
- Capitalize on Micron’s 24% Drop—Wall Street Eyes Major Upside
Receive News & Ratings for Nanobiotix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nanobiotix and related companies with MarketBeat.com's FREE daily email newsletter.
